|
1
|
Jayasinghe H, Kopsaftis Z and Carson K:
Asthma bronchiale and exercise-induced bronchoconstriction.
Respiration. 89:505–512. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reddel HK and Levy ML; Global Initiative
for Asthma Scientific Committee and Dissemination and
Implementation Committee, : The GINA asthma strategy report: What's
new for primary care? NPJ Prim Care Respir Med. 25:150502015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Becker AB and Abrams EM: Asthma
guidelines: The global initiative for asthma in relation to
national guidelines. Curr Opin Allergy Clin Immunol. 17:99–103.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fajt ML and Wenzel SE: Asthma phenotypes
and the use of biologic medications in asthma and allergic disease:
The next steps toward personalized care. J Allergy Clin Immunol.
135:299–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wenzel SE: Asthma phenotypes: The
evolution from clinical to molecular approaches. Nat Med.
18:716–725. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu S, Kim HY, Chang YJ, DeKruyff RH and
Umetsu DT: Innate lymphoid cells and asthma. J Allergy Clin
Immunol. 133:943–951. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
DeKruyff RH, Yu S, Kim HY and Umetsu DT:
Innate immunity in the lung regulates the development of asthma.
Immunol Rev. 260:235–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim HY, DeKruyff RH and Umetsu DT: The
many paths to asthma: Phenotype shaped by innate and adaptive
immunity. Nat Immunol. 11:577–584. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McKenzie AN: Type-2 innate lymphoid cells
in asthma and allergy. Ann Am Thorac Soc. 11 (Suppl 5):S263–S270.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Campbell KS and Hasegawa J: Natural killer
cell biology: An update and future directions. J Allergy Clin
Immunol. 132:536–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Varchetta S, Oliviero B, Mavilio D and
Mondelli MU: Different combinations of cytokines and activating
receptor stimuli are required for human natural killer cell
functional diversity. Cytokine. 62:58–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ndhlovu LC, Lopez-Vergès S, Barbour JD,
Jones RB, Jha AR, Long BR, Schoeffler EC, Fujita T, Nixon DF and
Lanier LL: Tim-3 marks human natural killer cell maturation and
suppresses cell-mediated cytotoxicity. Blood. 119:3734–3743. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Messaoudene M, Fregni G,
Fourmentraux-Neves E, Chanal J, Maubec E, Mazouz-Dorval S,
Couturaud B, Girod A, Sastre-Garau X, Albert S, et al: Mature
cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate
lymph nodes adjacent to metastatic melanoma. Cancer Res. 74:81–92.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chiossone L, Chaix J, Fuseri N, Roth C,
Vivier E and Walzer T: Maturation of mouse NK cells is a 4-stage
developmental program. Blood. 113:5488–5496. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Holmes ML, Huntington ND, Thong RP, Brady
J, Hayakawa Y, Andoniou CE, Fleming P, Shi W, Smyth GK,
Degli-Esposti MA, et al: Peripheral natural killer cell maturation
depends on the transcription factor Aiolos. EMBO J. 33:2721–2734.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Z, Chen X, Xu Y, Xiong P, Fang M, Tan
Z, Gong F and Zheng F: Collagenase digestion down-regulates the
density of CD27 on lymphocytes. J Immunol Methods. 413:57–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allan RS, Zueva E, Cammas F, Schreiber HA,
Masson V, Belz GT, Roche D, Maison C, Quivy JP, Almouzni G and
Amigorena S: An epigenetic silencing pathway controlling T helper 2
cell lineage commitment. Nature. 487:249–253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gray LEK and Sly PD: Update in asthma
2017. Am J Respir Crit Care Med. 197:1108–1115. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Poli A, Michel T, Patil N and Zimmer J:
Revisiting the functional impact of NK cells. Trends Immunol.
39:460–472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peters SP: Asthma phenotypes: Nonallergic
(intrinsic) asthma. J Allergy Clin Immunol Pract. 2:650–652. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schatz M and Rosenwasser L: The allergic
asthma phenotype. J Allergy Clin Immunol Pract. 2:645–649. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Steinke JW and Borish L: Th2 cytokines and
asthma. Interleukin-4: Its role in the pathogenesis of asthma and
targeting it for asthma treatment with interleukin-4 receptor
antagonists. Respir Res. 2:66–70. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Munitz A, Brandt EB, Mingler M, Finkelman
FD and Rothenberg ME: Distinct roles for IL-13 and IL-4 via IL-13
receptor alpha1 and the type II IL-4 receptor in asthma
pathogenesis. Proc Natl Acad Sci USA. 105:7240–7245. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rosenwasser LJ and Rothenberg ME: IL-5
pathway inhibition in the treatment of asthma and Churg-Strauss
syndrome. J Allergy Clin Immunol. 125:1245–1246. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ingram JL and Kraft M: IL-13 in asthma and
allergic disease: Asthma phenotypes and targeted therapies. J
Allergy Clin Immunol. 130:829–844. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lambrecht BN and Hammad H: Asthma and
coagulation. N Engl J Med. 369:1964–1966. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Helden MJ and Lambrecht BN: Dendritic
cells in asthma. Curr Opin Immunol. 25:745–754. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deniz G, van de Veen W and Akdis M:
Natural killer cells in patients with allergic diseases. J Allergy
Clin Immunol. 132:527–535. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Korsgren M, Persson CG, Sundler F, Bjerke
T, Hansson T, Chambers BJ, Hong S, Van Kaer L, Ljunggren HG and
Korsgren O: Natural killer cells determine development of
allergen-induced eosinophilic airway inflammation in mice. J Exp
Med. 189:553–562. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ple C, Barrier M, Amniai L, Marquillies P,
Bertout J, Tsicopoulos A, Walzer T, Lassalle P and Duez C: Natural
killer cells accumulate in lung-draining lymph nodes and regulate
airway eosinophilia in a murine model of asthma. Scand J Immunol.
72:118–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mathias CB, Guernsey LA, Zammit D, Brammer
C, Wu CA, Thrall RS and Aguila HL: Pro-inflammatory role of natural
killer cells in the development of allergic airway disease. Clin
Exp Allergy. 44:589–601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perricone R, Perricone C, De Carolis C and
Shoenfeld Y: NK cells in autoimmunity: A two-edg'd weapon of the
immune system. Autoimmun Rev. 7:384–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haeberlein S, Sebald H, Bogdan C and
Schleicher U: IL-18, but not IL-15, contributes to the
IL-12-dependent induction of NK-cell effector functions by
Leishmania infantum in vivo. Eur J Immunol. 40:1708–1717. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hoshino T, Winkler-Pickett RT, Mason AT,
Ortaldo JR and Young HA: IL-13 production by NK cells:
IL-13-producing NK and T cells are present in vivo in the absence
of IFN-gamma. J Immunol. 162:51–59. 1999.PubMed/NCBI
|
|
35
|
McDermott JR, Humphreys NE, Forman SP,
Donaldson DD and Grencis RK: Intraepithelial NK cell-derived IL-13
induces intestinal pathology associated with nematode infection. J
Immunol. 175:3207–3213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Aktas E, Akdis M, Bilgic S, Disch R, Falk
CS, Blaser K, Akdis C and Deniz G: Different natural killer (NK)
receptor expression and immunoglobulin E (IgE) regulation by NK1
and NK2 cells. Clin Exp Immunol. 140:301–309. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fahy JV: Type 2 inflammation in
asthma-present in most, absent in many. Nat Rev Immunol. 15:57–65.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Holgate ST: Innate and adaptive immune
responses in asthma. Nat Med. 18:673–683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sceneay J, Chow MT, Chen A, Halse HM, Wong
CS, Andrews DM, Sloan EK, Parker BS, Bowtell DD, Smyth MJ and
Möller A: Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+
immune suppressor cells and compromises NK cell cytotoxicity in the
premetastatic niche. Cancer Res. 72:3906–3911. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yanagisawa K, Exley MA, Jiang X, Ohkochi
N, Taniguchi M and Seino K: Hyporesponsiveness to natural killer
T-cell ligand alpha-galactosylceramide in cancer-bearing state
mediated by CD11b+ Gr-1+ cells producing nitric oxide. Cancer Res.
66:11441–11446. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Clinthorne JF, Beli E, Duriancik DM and
Gardner EM: NK cell maturation and function in C57BL/6 mice are
altered by caloric restriction. J Immunol. 190:712–722. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mao Y, Sarhan D, Steven A, Seliger B,
Kiessling R and Lundqvist A: Inhibition of tumor-derived
prostaglandin-e2 blocks the induction of myeloid-derived suppressor
cells and recovers natural killer cell activity. Clin Cancer Res.
20:4096–4106. 2014. View Article : Google Scholar : PubMed/NCBI
|
